BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30034947)

  • 1. ALARM NMR for HTS triage and chemical probe validation.
    Dahlin JL; Cuellar M; Singh G; Nelson KM; Strasser J; Rappe T; Xia Y; Veglia G; Walters MA
    Curr Protoc Chem Biol; 2018 Mar; 10(1):91-117. PubMed ID: 30034947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens.
    Huth JR; Mendoza R; Olejniczak ET; Johnson RW; Cothron DA; Liu Y; Lerner CG; Chen J; Hajduk PJ
    J Am Chem Soc; 2005 Jan; 127(1):217-24. PubMed ID: 15631471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.
    Dahlin JL; Nissink JW; Strasser JM; Francis S; Higgins L; Zhou H; Zhang Z; Walters MA
    J Med Chem; 2015 Mar; 58(5):2091-113. PubMed ID: 25634295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors.
    Dahlin JL; Nelson KM; Strasser JM; Barsyte-Lovejoy D; Szewczyk MM; Organ S; Cuellar M; Singh G; Shrimp JH; Nguyen N; Meier JL; Arrowsmith CH; Brown PJ; Baell JB; Walters MA
    Nat Commun; 2017 Nov; 8(1):1527. PubMed ID: 29142305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.
    Dahlin JL; Nissink JWM; Francis S; Strasser JM; John K; Zhang Z; Walters MA
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4740-4752. PubMed ID: 26318992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance.
    Huth JR; Song D; Mendoza RR; Black-Schaefer CL; Mack JC; Dorwin SA; Ladror US; Severin JM; Walter KA; Bartley DM; Hajduk PJ
    Chem Res Toxicol; 2007 Dec; 20(12):1752-9. PubMed ID: 18001056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in discovering small molecules to probe protein function in a systems context.
    Doyle SK; Pop MS; Evans HL; Koehler AN
    Curr Opin Chem Biol; 2016 Feb; 30():28-36. PubMed ID: 26615565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying a high-throughput fluorescence polarization assay for the discovery of chemical probes blocking La:RNA interactions in vitro and in cells.
    Sommer G; Fedarovich A; Kota V; Rodriguez R; Smith CD; Heise T
    PLoS One; 2017; 12(3):e0173246. PubMed ID: 28291789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery.
    Wang Y; Cornett A; King FJ; Mao Y; Nigsch F; Paris CG; McAllister G; Jenkins JL
    Cell Chem Biol; 2016 Jul; 23(7):862-874. PubMed ID: 27427232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic assay of the Michael addition-like thiol-ene reaction and insight into protein bioconjugation.
    Ma FH; Chen JL; Li QF; Zuo HH; Huang F; Su XC
    Chem Asian J; 2014 Jul; 9(7):1808-16. PubMed ID: 24850806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probe molecule (PrM) approach in adverse outcome pathway (AOP) based high-throughput screening (HTS): in vivo discovery for developing in vitro target methods.
    Angrish MM; Madden MC; Pleil JD
    Chem Res Toxicol; 2015 Apr; 28(4):551-9. PubMed ID: 25692543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethylsilyl tag for probing protein-ligand interactions by NMR.
    Becker W; Adams LA; Graham B; Wagner GE; Zangger K; Otting G; Nitsche C
    J Biomol NMR; 2018 Apr; 70(4):211-218. PubMed ID: 29564580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead discovery for mammalian elongation of long chain fatty acids family 6 using a combination of high-throughput fluorescent-based assay and RapidFire mass spectrometry assay.
    Takamiya M; Sakurai M; Teranishi F; Ikeda T; Kamiyama T; Asai A
    Biochem Biophys Res Commun; 2016 Nov; 480(4):721-726. PubMed ID: 27793673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules.
    Yu W; Lakkaraju SK; Raman EP; Fang L; MacKerell AD
    J Chem Inf Model; 2015 Feb; 55(2):407-20. PubMed ID: 25622696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and affordable screening platform for membrane protein trafficking.
    Snyder JC; Pack TF; Rochelle LK; Chakraborty SK; Zhang M; Eaton AW; Bai Y; Ernst LA; Barak LS; Waggoner AS; Caron MG
    BMC Biol; 2015 Dec; 13():107. PubMed ID: 26678094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds.
    Proj M; Knez D; Sosič I; Gobec S
    Drug Discov Today; 2022 Jun; 27(6):1733-1742. PubMed ID: 35301150
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.